Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMR vaccine for COVID-19 prevention in health care professionals
PACTR202006883882711Phase 3Not yet recruiting
- Sponsor
- Dar Al Fouad Hospital
- Start
- Jul 2020
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing MMR vaccine with Placebo (2 arms). Primary endpoints: COVID-19 incidence and Asymptomatic or mild COVID-19 disease. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
M-M-R II
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202006883882711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006883882711.